Search research articles
Contact Us
Filters
Showing results (1-10 of 1,213) with videos related to
Page
of 122
Sort By:
The American Journal of Psychiatry
|
December 2, 2021
Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg
Roger S McIntyre
The Journal of Clinical Psychiatry
|
December 1, 2011
Implementing guideline-based strategies to avoid relapse and recurrence in depression
Roger S McIntyre
Expert Opinion on Drug Safety
|
September 2, 2008
Varenicline and suicidality: a new era in medication safety surveillance
Roger S McIntyre
The American Journal of Psychiatry
|
October 1, 2021
Surrogate Markers of Insulin Resistance in Predicting Major Depressive Disorder: Metabolism Metastasizes to the Brain
Roger S McIntyre
CNS Spectrums
|
June 2, 2025
Response to letter "transgenerational adverse effects of valproate can't be by-passed"
Roger S McIntyre
The Journal of Clinical Psychiatry
|
July 3, 2009
Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey
Roger S McIntyre
The Journal of Clinical Psychiatry
|
June 5, 2024
The Co-occurrence of Depression and Obesity: Implications for Clinical Practice and the Discovery of Targeted and Precise Mechanistically Informed Therapeutics
Roger S McIntyre
Expert Opinion on Drug Safety
|
August 15, 2023
Serotonin 5-HT<sub>2B</sub> receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents
Roger S McIntyre
Biological Psychiatry
|
June 18, 2016
Sleep and Inflammation: Implications for Domain Approach and Treatment Opportunities
Roger S McIntyre
Expert Opinion on Drug Safety
|
March 23, 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
Roger S McIntyre
Page
of 122
Search research articles
Search
Showing results (1-10 of 1,213) with videos related to
Sort By:
Page
of 122
The American Journal of Psychiatry
|
December 2, 2021
Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg
Roger S McIntyre
The Journal of Clinical Psychiatry
|
December 1, 2011
Implementing guideline-based strategies to avoid relapse and recurrence in depression
Roger S McIntyre
Expert Opinion on Drug Safety
|
September 2, 2008
Varenicline and suicidality: a new era in medication safety surveillance
Roger S McIntyre
The American Journal of Psychiatry
|
October 1, 2021
Surrogate Markers of Insulin Resistance in Predicting Major Depressive Disorder: Metabolism Metastasizes to the Brain
Roger S McIntyre
CNS Spectrums
|
June 2, 2025
Response to letter "transgenerational adverse effects of valproate can't be by-passed"
Roger S McIntyre
The Journal of Clinical Psychiatry
|
July 3, 2009
Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey
Roger S McIntyre
The Journal of Clinical Psychiatry
|
June 5, 2024
The Co-occurrence of Depression and Obesity: Implications for Clinical Practice and the Discovery of Targeted and Precise Mechanistically Informed Therapeutics
Roger S McIntyre
Expert Opinion on Drug Safety
|
August 15, 2023
Serotonin 5-HT<sub>2B</sub> receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents
Roger S McIntyre
Biological Psychiatry
|
June 18, 2016
Sleep and Inflammation: Implications for Domain Approach and Treatment Opportunities
Roger S McIntyre
Expert Opinion on Drug Safety
|
March 23, 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
Roger S McIntyre
Page
of 122